No Data
No Data
Yisheng Pharmaceutical: Report for the third quarter of 2024
Jilin Jian Yisheng Pharmaceutical: Half-year report for the year 2024.
Jilin Jian Yisheng Pharmaceutical: Summary of Half-Year Report in 2024.
Jilin Jian Yisheng Pharmaceutical (002566.SZ): The net income in the first half of the year was 33.3358 million yuan, a year-on-year decrease of 29.71%.
Jilin Jian Yisheng Pharmaceutical (002566.SZ) announced its semi-annual report for 2024, with a total operating income of 0.348 billion yuan during the reporting period, a year-on-year decrease of 25.90%; the net income attributable to shareholders of the listed company was 33.3358 million yuan, a year-on-year decrease of 29.71%; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 20.3051 million yuan, a year-on-year decrease of 45.04%; the basic earnings per share was 0.1007 yuan.
As of August 10th, 2024, the total number of shareholders of Jilin Jian Yisheng Pharmaceutical (002566.SZ) was 23,565.
Jilin Jian Yisheng Pharmaceutical (002566.SZ) stated on the investor interaction platform on August 13th that as of August 10th, 2024, the total number of shareholders in the company was 23,565.
As of July 19, 2024, the total number of shareholders for Jilin Jian Yisheng Pharmaceutical (002566.SZ) is 23,832.
On July 24th, Gelunhui reported that as of July 19th, 2024, the total number of shareholders of Jilin Jian Yisheng Pharmaceutical (002566.SZ) was 23,832.